73.89
前日終値:
$75.00
開ける:
$73.84
24時間の取引高:
96,692
Relative Volume:
0.05
時価総額:
$37.18B
収益:
$10.03B
当期純損益:
$1.07B
株価収益率:
34.05
EPS:
2.17
ネットキャッシュフロー:
$1.39B
1週間 パフォーマンス:
-5.08%
1か月 パフォーマンス:
-8.58%
6か月 パフォーマンス:
-20.43%
1年 パフォーマンス:
-25.24%
Alcon Inc Stock (ALC) Company Profile
ALC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ALC
Alcon Inc
|
73.90 | 37.18B | 10.03B | 1.07B | 1.39B | 2.17 |
![]()
ISRG
Intuitive Surgical Inc
|
434.67 | 160.51B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
181.49 | 53.46B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
RMD
Resmed Inc
|
266.00 | 40.35B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
257.00 | 18.03B | 2.96B | 487.70M | 344.00M | 6.68 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-21 | ダウングレード | JP Morgan | Overweight → Neutral |
2025-05-20 | ダウングレード | Deutsche Bank | Buy → Hold |
2025-05-14 | 繰り返されました | BTIG Research | Buy |
2025-03-28 | 繰り返されました | Needham | Buy |
2025-03-25 | アップグレード | BofA Securities | Neutral → Buy |
2025-01-24 | 繰り返されました | Needham | Buy |
2025-01-10 | アップグレード | Redburn Atlantic | Neutral → Buy |
2024-12-17 | 繰り返されました | Needham | Buy |
2024-11-12 | 繰り返されました | Needham | Buy |
2024-10-10 | アップグレード | Redburn Atlantic | Sell → Neutral |
2024-09-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2024-07-15 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
2024-05-15 | アップグレード | Oppenheimer | Perform → Outperform |
2024-04-10 | 開始されました | Goldman | Buy |
2024-03-14 | 開始されました | RBC Capital Mkts | Sector Perform |
2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
2024-01-23 | 開始されました | Bernstein | Outperform |
2023-12-18 | ダウングレード | Redburn Atlantic | Neutral → Sell |
2023-12-12 | 開始されました | Stifel | Buy |
2023-12-04 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2023-08-17 | アップグレード | JP Morgan | Neutral → Overweight |
2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
2023-05-10 | アップグレード | Robert W. Baird | Neutral → Outperform |
2023-03-01 | アップグレード | Societe Generale | Sell → Hold |
2022-12-22 | 開始されました | Mizuho | Buy |
2022-11-17 | ダウングレード | Societe Generale | Hold → Sell |
2022-08-11 | ダウングレード | Societe Generale | Buy → Hold |
2022-05-13 | 再開されました | Credit Suisse | Outperform |
2022-05-12 | アップグレード | Stephens | Equal-Weight → Overweight |
2022-04-08 | 開始されました | Needham | Buy |
2022-03-11 | 開始されました | BofA Securities | Buy |
2022-01-18 | ダウングレード | Stephens | Overweight → Equal-Weight |
2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2021-10-01 | 開始されました | Oppenheimer | Perform |
2021-07-14 | 開始されました | Deutsche Bank | Buy |
2021-05-06 | アップグレード | Citigroup | Sell → Neutral |
2021-03-22 | アップグレード | BTIG Research | Neutral → Buy |
2020-11-12 | ダウングレード | Guggenheim | Buy → Neutral |
2020-07-06 | ダウングレード | Citigroup | Neutral → Sell |
2020-07-06 | 開始されました | KeyBanc Capital Markets | Sector Weight |
2020-06-16 | アップグレード | Guggenheim | Neutral → Buy |
2020-04-08 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2020-03-26 | アップグレード | Argus | Hold → Buy |
2020-03-24 | アップグレード | Societe Generale | Sell → Hold |
2020-03-13 | アップグレード | UBS | Neutral → Buy |
2020-03-05 | 開始されました | Citigroup | Neutral |
2020-02-26 | アップグレード | Berenberg | Hold → Buy |
2020-01-08 | 開始されました | Argus | Hold |
2019-10-29 | 開始されました | Stephens | Equal-Weight |
2019-08-21 | 繰り返されました | BofA/Merrill | Neutral |
2019-06-24 | 開始されました | SVB Leerink | Mkt Perform |
2019-06-14 | 開始されました | BTIG Research | Neutral |
2019-05-10 | 開始されました | Robert W. Baird | Outperform |
2019-05-02 | 開始されました | Credit Suisse | Outperform |
すべてを表示
Alcon Inc (ALC) 最新ニュース
Alcon unveils $60M facility expansion in Cabell County - WOWK 13 News
Alcon investing $60 million in its West Virginia facility in Cabell County - WCHS
Alcon AG stock hits 52-week low at $74.83 By Investing.com - Investing.com UK
Broadwood opposes Alcon’s acquisition of STAAR Surgical - Investing.com India
Broadwood opposes Alcon’s acquisition of STAAR Surgical By Investing.com - Investing.com South Africa
STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates Fairness of Proposed STAAR Surgical Company (NASDAQ: STAA) Shareholder Buyout and Encourages Investors to Contact the Firm to Discuss their Legal Rights and Options - GlobeNewswire Inc.
Alcon Move to Acquire STAAR Surgical for $1.5 Billion Opposed by Broadwood Partners - MarketScreener
Broadwood Partners (27.5% Owner) Opposes STAAR's $28/Share Alcon Deal | STAA Stock News - Stock Titan
Alcon considers moving manufacturing lines to Fort Worth from Europe, creating hundreds of jobs - The Business Journals
Major shareholder Yunqi Capital to vote against Staar Surgical 's proposed sale to Alcon - MSN
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why - Stocktwits
STAAR confirms no competing bids emerged during Alcon merger window By Investing.com - Investing.com Nigeria
STAAR draws no rival bids as Yunqi joins Broadwood against Alcon deal - Investing.com Canada
Yunqi Capital opposes STAAR Surgical’s merger with Alcon By Investing.com - Investing.com South Africa
STAAR confirms no competing bids emerged during Alcon merger window - Investing.com India
Staar has no competing bids, another shareholder rejects Alcon buy - BioWorld MedTech
Yunqi Capital Announces its opposition to the STAAR Surgical? s proposed sale to Alcon - MarketScreener
Merger Agreement Advances as Alcon (ALC) Clears 'Window Shop' Pe - GuruFocus
Fort Worth weighs incentives for Alcon; Dallas mulls permit for outdoor concerts in Design District - The Business Journals
Yunqi Capital Opposes Staar Surgical (STAA) Sale to Alcon - GuruFocus
Yunqi Capital Rejects Alcon's Acquisition Proposal of STAAR Surg - GuruFocus
Yunqi Capital opposes STAAR Surgical’s merger with Alcon - Investing.com
Staar Surgical urges shareholders to back Alcon merger as “window shop” period ends (STAA:NASDAQ) - Seeking Alpha
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon - Bluefield Daily Telegraph
$28 vs Previous $55 Offer: Major STAAR Surgical Investor Yunqi Capital Fights Against 'Undervalued' Alcon Deal - Stock Titan
Refractive Surgery Market Booming Rapidly by 2032: Alcon Inc., Johnson & Johnson Vision, Bausch + Lomb - openPR.com
Trade Recap: Does Alcon Inc stock benefit from AI growthPortfolio Value Summary & Verified Short-Term Plans - خودرو بانک
VIX Spike: Is Alcon Incs growth already priced inDip Buying & Free Community Consensus Stock Picks - khodrobank.com
Pullback Watch: What is the next catalyst for PTMNTrade Risk Assessment & Weekly High Return Forecasts - khodrobank.com
Bond Watch: Will Alcon Inc benefit from rate cutsMarket Activity Summary & Reliable Price Breakout Signals - khodrobank.com
Fuchs endothelial corneal dystrophy Market Analysis: Epidemiology Insights, Therapies, Companies, by DelveInsight | Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon - Barchart.com
Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up - Nasdaq
Aug Retail: Should I hold or sell Tectonic Therapeutic Inc. nowIPO Watch & AI Enhanced Market Trend Forecasts - خودرو بانک
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
Alcon AG stock hits 52-week low at $77.34 amid challenging year By Investing.com - Investing.com South Africa
Alcon AG stock hits 52-week low at $77.34 amid challenging year - Investing.com Australia
Growth Value: What is Alcon Inc.’s book value per share2025 Year in Review & High Accuracy Investment Signals - خودرو بانک
Gains Report: What is Bakkt Holdings Inc Equity Warrants 5 year growth outlook2025 Top Gainers & Free High Accuracy Swing Entry Alerts - خودرو بانک
Staar Surgical issues letter to stockholders regarding Alcon merger - Yahoo Finance
Trading Action: Is Alcon Inc forming a breakout patternJuly 2025 Volume & Fast Moving Stock Watchlists - خودرو بانک
Alcon upgraded to neutral by Redburn, operational execution cited - MSN
Tools to monitor Alcon Inc. recovery probabilityInsider Selling & Daily Market Momentum Tracking - newser.com
STAAR Surgical Announces Merger with Alcon - TipRanks
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $100.73 - 富途牛牛
Fuchs Endothelial Corneal Dystrophy Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | ProQR Therapeutics, Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon Inc., Emmecell - Barchart.com
51% Premium: Medical Device Leader Alcon to Acquire STAAR Surgical in Premium Cash Deal Worth $28 Per Share - Stock Titan
Alcon (ALC) Boosts Surgical Efficiency with Unity Vitreoretinal Cataract System - GuruFocus
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS - Yahoo Finance
Risk Check: Whats the MACD signal for Alcon IncShare Buyback & Consistent Income Trade Ideas - خودرو بانک
Alcon (ALC) to Acquire Staar Surgical in $28 Per Share Cash Deal - GuruFocus
Alcon (ALC) Receives a Buy from RBC Capital - The Globe and Mail
Alcon Inc (ALC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):